Advertisement

Index by author

April 01, 1996; Volume 24,Issue 4

A

  1. Abbott, F S

    1. Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases.
      W Tang, A G Borel and F S Abbott
      Drug Metabolism and Disposition April 1996, 24 (4) 436-446;

  2. Alabaster, C T

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

B

  1. Ball, S E

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

  2. Bammler, T K

    1. A comparative study of hepatic and colonic metabolic enzymes in inbred mouse lines before and after treatment with the colon carcinogen, 1,2-dimethylhydrazine.
      D A Delker, T K Bammler and D W Rosenberg
      Drug Metabolism and Disposition April 1996, 24 (4) 408-413;

  3. Barfuss, D W

    1. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
      R K Zalups and D W Barfuss
      Drug Metabolism and Disposition April 1996, 24 (4) 480-486;

  4. Bauwens, J E

    1. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

  5. Black, D J

    1. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

  6. Borel, A G

    1. Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases.
      W Tang, A G Borel and F S Abbott
      Drug Metabolism and Disposition April 1996, 24 (4) 436-446;

  7. Boucher, J L

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

  8. Burka, L T

    1. Excretion and identification of methacrylonitrile metabolites in the bile of male F344 rats.
      B I Ghanayem and L T Burka
      Drug Metabolism and Disposition April 1996, 24 (4) 390-394;

C

  1. Chapron, D J

    1. Concentration-dependent tubular secretion of acetazolamide and its inhibition by salicylic acid in the isolated perfused rat kidney.
      D R Taft, D J Chapron, D J Fournier and K R Sweeney
      Drug Metabolism and Disposition April 1996, 24 (4) 456-461;

  2. Cone, E J

    1. Incorporation of codeine and metabolites into hair. Role of pigmentation.
      S P Gygi, R E Joseph, E J Cone, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition April 1996, 24 (4) 495-501;

  3. Congrave, G S

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

D

  1. Delaforge, M

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

  2. Delker, D A

    1. A comparative study of hepatic and colonic metabolic enzymes in inbred mouse lines before and after treatment with the colon carcinogen, 1,2-dimethylhydrazine.
      D A Delker, T K Bammler and D W Rosenberg
      Drug Metabolism and Disposition April 1996, 24 (4) 408-413;

  3. Durst, F

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

E

  1. Evans, J S

    1. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

F

  1. Fournier, D J

    1. Concentration-dependent tubular secretion of acetazolamide and its inhibition by salicylic acid in the isolated perfused rat kidney.
      D R Taft, D J Chapron, D J Fournier and K R Sweeney
      Drug Metabolism and Disposition April 1996, 24 (4) 456-461;

  2. Franklin, M R

    1. Effect of total parenteral nutrition containing lipid calories on hepatic drug metabolism in rats.
      R B Raftogianis, M R Franklin and R E Galinsky
      Drug Metabolism and Disposition April 1996, 24 (4) 502-505;

  3. Freeman, J P

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

G

  1. Galinsky, R E

    1. Effect of total parenteral nutrition containing lipid calories on hepatic drug metabolism in rats.
      R B Raftogianis, M R Franklin and R E Galinsky
      Drug Metabolism and Disposition April 1996, 24 (4) 502-505;

  2. Ghanayem, B I

    1. Excretion and identification of methacrylonitrile metabolites in the bile of male F344 rats.
      B I Ghanayem and L T Burka
      Drug Metabolism and Disposition April 1996, 24 (4) 390-394;

  3. Gidal, B E

    1. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

  4. Guengerich, F P

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  5. Gygi, S P

    1. Incorporation of codeine and metabolites into hair. Role of pigmentation.
      S P Gygi, R E Joseph, E J Cone, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition April 1996, 24 (4) 495-501;

H

  1. Hargreaves, M B

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

  2. Hwang, I Y

    1. A gas-liquid system for enzyme kinetic studies of volatile organic chemicals. Determination of enzyme kinetic constants and partition coefficients of trichloroethylene.
      I Y Hwang, K F Reardon, J D Tessari and R S Yang
      Drug Metabolism and Disposition April 1996, 24 (4) 377-382;

  3. Hyland, R

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

J

  1. Jones, B C

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

  2. Joseph, R E

    1. Incorporation of codeine and metabolites into hair. Role of pigmentation.
      S P Gygi, R E Joseph, E J Cone, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition April 1996, 24 (4) 495-501;

K

  1. Kadlubar, F F

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  2. Kao, J

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

  3. King, R S

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  4. Koop, D R

    1. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.
      M B Sewer, D R Koop and E T Morgan
      Drug Metabolism and Disposition April 1996, 24 (4) 401-407;

  5. Kunze, K L

    1. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
      K L Kunze, L C Wienkers, K E Thummel and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 414-421;
    2. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;
    3. Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction.
      K L Kunze and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 429-435;

L

  1. Lang, N P

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  2. Lim, H K

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

M

  1. Madden, S

    1. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).
      S Madden, J L Maggs and B K Park
      Drug Metabolism and Disposition April 1996, 24 (4) 469-479;

  2. Maggs, J L

    1. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).
      S Madden, J L Maggs and B K Park
      Drug Metabolism and Disposition April 1996, 24 (4) 469-479;

  3. McDonnell, N D

    1. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

  4. Miller, D W

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  5. Mioskowski, C

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

  6. Morgan, E T

    1. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.
      M B Sewer, D R Koop and E T Morgan
      Drug Metabolism and Disposition April 1996, 24 (4) 401-407;

P

  1. Park, B K

    1. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).
      S Madden, J L Maggs and B K Park
      Drug Metabolism and Disposition April 1996, 24 (4) 469-479;

  2. Pflieger, P

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

  3. Pinot, F

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

R

  1. Raftogianis, R B

    1. Effect of total parenteral nutrition containing lipid calories on hepatic drug metabolism in rats.
      R B Raftogianis, M R Franklin and R E Galinsky
      Drug Metabolism and Disposition April 1996, 24 (4) 502-505;

  2. Raza, H

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  3. Reardon, K F

    1. A gas-liquid system for enzyme kinetic studies of volatile organic chemicals. Determination of enzyme kinetic constants and partition coefficients of trichloroethylene.
      I Y Hwang, K F Reardon, J D Tessari and R S Yang
      Drug Metabolism and Disposition April 1996, 24 (4) 377-382;

  4. Reed, L J

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

  5. Rollins, D E

    1. Incorporation of codeine and metabolites into hair. Role of pigmentation.
      S P Gygi, R E Joseph, E J Cone, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition April 1996, 24 (4) 495-501;

  6. Rosenberg, D W

    1. A comparative study of hepatic and colonic metabolic enzymes in inbred mouse lines before and after treatment with the colon carcinogen, 1,2-dimethylhydrazine.
      D A Delker, T K Bammler and D W Rosenberg
      Drug Metabolism and Disposition April 1996, 24 (4) 408-413;

S

  1. Salaün, J P

    1. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
      J L Boucher, M Delaforge, J P Salaün, F Pinot, F Durst, P Pflieger and C Mioskowski
      Drug Metabolism and Disposition April 1996, 24 (4) 462-468;

  2. Scatina, J

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

  3. Seaton, T L

    1. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

  4. Sewer, M B

    1. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.
      M B Sewer, D R Koop and E T Morgan
      Drug Metabolism and Disposition April 1996, 24 (4) 401-407;

  5. Sharer, J E

    1. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
      J E Sharer and S A Wrighton
      Drug Metabolism and Disposition April 1996, 24 (4) 487-494;

  6. Sisenwine, S F

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

  7. Smith, D A

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

  8. Squires, R B

    1. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
      H Raza, R S King, R B Squires, F P Guengerich, D W Miller, J P Freeman, N P Lang and F F Kadlubar
      Drug Metabolism and Disposition April 1996, 24 (4) 395-400;

  9. Sweeney, K R

    1. Concentration-dependent tubular secretion of acetazolamide and its inhibition by salicylic acid in the isolated perfused rat kidney.
      D R Taft, D J Chapron, D J Fournier and K R Sweeney
      Drug Metabolism and Disposition April 1996, 24 (4) 456-461;

T

  1. Taft, D R

    1. Concentration-dependent tubular secretion of acetazolamide and its inhibition by salicylic acid in the isolated perfused rat kidney.
      D R Taft, D J Chapron, D J Fournier and K R Sweeney
      Drug Metabolism and Disposition April 1996, 24 (4) 456-461;

  2. Tang, W

    1. Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases.
      W Tang, A G Borel and F S Abbott
      Drug Metabolism and Disposition April 1996, 24 (4) 436-446;

  3. Tessari, J D

    1. A gas-liquid system for enzyme kinetic studies of volatile organic chemicals. Determination of enzyme kinetic constants and partition coefficients of trichloroethylene.
      I Y Hwang, K F Reardon, J D Tessari and R S Yang
      Drug Metabolism and Disposition April 1996, 24 (4) 377-382;

  4. Thiel, V E

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

  5. Thummel, K E

    1. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
      K L Kunze, L C Wienkers, K E Thummel and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 414-421;

  6. Tio, C O

    1. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices.
      S E Ball, V E Thiel, C O Tio, H K Lim, J Kao, S F Sisenwine and J Scatina
      Drug Metabolism and Disposition April 1996, 24 (4) 383-389;

  7. Trager, W F

    1. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
      K L Kunze, L C Wienkers, K E Thummel and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 414-421;
    2. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;
    3. Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction.
      K L Kunze and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 429-435;

W

  1. Walker, D K

    1. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
      D K Walker, C T Alabaster, G S Congrave, M B Hargreaves, R Hyland, B C Jones, L J Reed and D A Smith
      Drug Metabolism and Disposition April 1996, 24 (4) 447-455;

  2. Wienkers, L C

    1. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
      K L Kunze, L C Wienkers, K E Thummel and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 414-421;
    2. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
      D J Black, K L Kunze, L C Wienkers, B E Gidal, T L Seaton, N D McDonnell, J S Evans, J E Bauwens and W F Trager
      Drug Metabolism and Disposition April 1996, 24 (4) 422-428;

  3. Wilkins, D G

    1. Incorporation of codeine and metabolites into hair. Role of pigmentation.
      S P Gygi, R E Joseph, E J Cone, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition April 1996, 24 (4) 495-501;

  4. Wrighton, S A

    1. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
      J E Sharer and S A Wrighton
      Drug Metabolism and Disposition April 1996, 24 (4) 487-494;

Y

  1. Yang, R S

    1. A gas-liquid system for enzyme kinetic studies of volatile organic chemicals. Determination of enzyme kinetic constants and partition coefficients of trichloroethylene.
      I Y Hwang, K F Reardon, J D Tessari and R S Yang
      Drug Metabolism and Disposition April 1996, 24 (4) 377-382;

Z

  1. Zalups, R K

    1. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
      R K Zalups and D W Barfuss
      Drug Metabolism and Disposition April 1996, 24 (4) 480-486;
Back to top

In this issue